EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs1697421 |
| Chromosomal location | Chr1: 21,695,879 (1p36.12) |
| Gene (distance) | ALPL (-12,565) |
| Predicted causal gene | ALPL |
| Gene/protein classification | - |
| Metabolite (Pathway) | DSGEGDFXAEGGGVR* (Fibrinogen cleavage peptide; Peptide) ADpSGEGDFXAEGGGVR* (Fibrinogen cleavage peptide; Peptide) |
| Biochemical locus-metabolite relationship | ALPL encodes a phosphatase, which could possibly have a bearing on the phosphorylation state of fibrinogen. The alpha chain of fibrinogen is known to be phosphorylated at Ser22 [16807684]. Ratio interpretation: indicates likely substrate/product pair ('activity'). ALPL plausibly affects phosphorylation state of fibrinogen |
| eQTL associations | ALPL (S) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information |
| Complex trait associations | Phosphorus levels [20558539] |
| Known metabolite associations | ADpSGEGDFXAEGGGVR*/DSGEGDFXAEGGGVR* [21886157] (r2=0.665 with rs10799701) |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | CHEMBL5979 |
| Drug information |
Approved drugs with activity in ChEMBL
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |